# A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients

> **NCT00479076** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 22 (estimated)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** aflibercept (AVE0005)
- **DRUG:** S-1

## Key facts

- **NCT ID:** NCT00479076
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2011-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00479076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00479076, "A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT00479076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*